Where does Veracyte, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Veracyte, Inc. ranks #18,262 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Veracyte, Inc. hold?

Veracyte, Inc. holds 16 US utility patents granted between 2016 and 2025, spanning 9 technology areas.

What is Veracyte, Inc.'s Innovation Score?

Veracyte, Inc. has an Innovation Score of 38.3 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Veracyte, Inc.'s patent grant rate increasing or decreasing?

Veracyte, Inc.'s recent grant velocity is +60% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Veracyte, Inc.'s patents?

Veracyte, Inc.'s patents average 22.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Veracyte, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Veracyte, Inc.

Q: What technology areas does Veracyte, Inc. focus on?

Veracyte, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 16 patents, ranking #292 of 2,502 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 16 granted patents across 9 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Veracyte ranks #18,262 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 9 technology areas.

#18,262
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.3/100): 22.5
avg claims per patent: +60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18262 · US Corporation #18,262 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #18,262/49,997
PHOTO-FINISH Vapor
CPC-NARROW C12Q · 9 areas
INNOV-THIN 38.3/100
CLAIMS-DENSE 22.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +60% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Vapor Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Veracyte’s 38.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (26%) Velocity 4.4 pts (11%) Breadth 10.6 pts (28%) Claim depth 13.5 pts (35%)

Qualcomm Incorporated · highest

85
Veracyte · this assignee

38
3D Lighting… · lowest

7

What this shows Veracyte's Innovation Score is 38.3/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Veracyte?

Each dot is one of Veracyte’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Veracyte’s own 22.5 claims/patent is ABOVE the 17.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Veracyte vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Veracyte's grants concentrate

Veracyte, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2016. By volume, Veracyte sits between Vapor Technologies, Inc. and Vidatronic, Inc..

Veracyte's three-year grant acceleration

Veracyte, Inc. shows 4 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Vapor

16
Veex

16
Vectra Networks

16
Venus Concept

16
Vermont Slate & C…

16
Versata

16
Vertiv Tech

16
Vidatronic

16
Veracyte ◀

16

What this shows Veracyte holds 16 patents at rank #18,265, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Veracyte

By rank, the assignees closest to #18,265 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Veracyte's primary technology class.

Veracyte's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Veracyte, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	6.3%
2018	2	12.5%
2019	2	12.5%
2020	3	18.8%
2021	1	6.3%
2022	1	6.3%
2023	1	6.3%
2024	2	12.5%
2025partial year	3	18.8%

Which technologies does Veracyte, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 16

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 11

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 9

Y02A - Technologies FOR Adaptation TO Climate Change 8

G06N - Computing Arrangements Based ON Specific Computational Models 8

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Veracyte, Inc.'s patent record in context - here's where to go next.

Veracyte, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 100% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #18,262 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Veracyte, Inc. against Vapor Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.